🇺🇸 FDA
Patent

US 9248131

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

granted A61KA61K31/196A61K31/24

Quick answer

US patent 9248131 (Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/196, A61K31/24, A61K31/341, A61K31/4402